Latest Sildenafil Stories
Viagra, the famous little blue pill that millions of men use for erectile dysfunction, and originally developed to help ailing hearts, may now also help treat heart symptoms of muscular dystrophy.
Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs, reveals an article in this week's BMJ.
Product marketed for sexual enhancement is contaminated with potentially dangerous ingredient SILVER SPRING, Md., Aug. 25 /PRNewswire-USNewswire/ -- The U.S.
CRANBURY, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc.
The Milwaukee Teachers' Education Association union is asking a judge to force the region's school board to reinstate Viagra and other erectile dysfunction drugs to their taxpayer-funded health care coverage.
CRANBURY, N.J., June 24 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc.
Product marketed as sexual enhancement is contaminated with potentially dangerous ingredient SILVER SPRING, Md., June 19 /PRNewswire-USNewswire/ -- The U.S.
The drug industryâ€™s latest attempt to find a female equivalent to Viagra fell short in two separate studies, according to federal regulators on Wednesday.
The FDA annoucned that it has warned Pfizer Inc for failing to quickly report serious and unexpected potential side effects from its drugs that have already been placed on the market.
WALTHAM, Mass., June 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while United Therapeutics' Tyvaso and Adcirca--launched in 2009--are each prescribed by more than half of surveyed pulmonologists in the specialized pulmonary arterial hypertension (PAH) center setting, Adcirca is much more widely used than Tyvaso among surveyed non-PAH-center physicians. The new Physician & Payer Forum...